Print Share

Low scores on a cancer-recurrence gene test may allow breast cancer patients to skip chemotherapy

Institution:

Albert Einstein College of Medicine

Researchers:

Joseph A. Sparano, MD, professor of medicine and of obstetrics and gynecology and women’s health at Albert Einstein College of Medicine, vice chairman of medical oncology at Montefiore Einstein Center for Cancer Care

Impact:

The study illustrates how genetic information is transforming cancer care and could change the way breast cancer is currently treated.

Timeline:

Published in the New England Journal of Medicine in 2015

Topics

AgingBasic ScienceCancerCardiovascularClinical ResearchDiagnosticsDrug DevelopmentFeaturedGeneticsImmune SystemInfectious DiseaseMedical DeviceMental HealthNeurodegenerativeNobel PrizePediatricsPublic HealthRespiratorySurgical AdvancementTechnologyTreatment AdvancesVaccines

Schools

Albany Medical CollegeAlbert Einstein College of MedicineCity University of New York School of MedicineColumbia University College Of Physicians and SurgeonsHofstra Northwell School of Medicine at Hofstra UniversityIcahn School of Medicine at Mount SinaiJacobs School of Medicine and Biomedical Sciences, the University at BuffaloNew York Institute of Technology College of Osteopathic MedicineNew York Medical CollegeNew York University School of MedicineSchool of Medicine and Dentistry at the University of Rochester Medical CenterStony Brook University School of MedicineSUNY Downstate Medical CenterSUNY Upstate Medical UniversityTouro College of Osteopathic MedicineWeill Cornell MedicineWeill Cornell Medicine, NewYork-Presbyterian